Beijing LabTech Instruments Co., Ltd. (LabTech, stock code: 688056.SH) completed its IPO and listing on the SSE STAR Market on September 2, 2020, raising approximately CNY 420 million at CNY 24.80 per share.
LabTech is a technology company that develops, manufactures and distributes laboratory equipment and scientific instruments. Since its founding, the company has developed fully-automatic laboratory detection platforms, integrated detection and laboratory analysis procedures such as sample collection and treatment, automatic sample injection, analysis and detection, and intelligent data analysis, covering and connecting all aspects of laboratory analysis. In addition, it has provided automatic and systematic laboratory analysis and detection solutions to clients in fields such as environmental monitoring, food detection, healthcare and life sciences, and geological sciences. LabTech’s products and services include laboratory analysis instruments, sample pre-treatment instruments, laboratory equipment, medical devices, laboratory consumables and laboratory engineering construction. The company has renowned brands like LabTech, CDS and Empore, R&D and production bases in China and the U.S., and product marketing and service centers in Beijing, Hong Kong, Boston and other cities. The company can provide integrated solutions from laboratory construction to sample analysis to various clients in China and around the world. To date, the company has exported products to over 90 countries and served nearly 30,000 clients. The company has been selected as “the most influential enterprise in instruments and devices in China” by the media for many years.
As the adviser to the issuer, Jingtian & Gongcheng’s legal team provided comprehensive legal services in relation to LabTech’s IPO and listing, including legal due diligence, advising on its restructuring, delivering legal reports and legal opinions for the company’s IPO and listing, and responding to regulatory inquiries from the stock exchange, and successfully concluding LabTech's IPO and listing.
